Possible Predictors of Adverse Outcomes in Children with Acute Viral Hepatitis in a Low-Middle-Income Country

低收入和中等收入国家儿童急性病毒性肝炎不良预后的可能预测因素

阅读:1

Abstract

OBJECTIVE: This study aimed to investigate the causes, clinical presentations, and biochemical profiles of children with acute viral hepatitis (AVH) while identifying potential factors that may predict mortality in these cases. MATERIALS AND METHODS: This study was conducted in the Bangabandhu Sheikh Mujib Medical University (currently Bangladesh Medical University) setting among 158 children between July 2022 and November 2024. Children (≤ 18 years) who exhibited symptoms of AVH were enrolled in the study. A comprehensive history, physical examination, and relevant investigations were documented. Patients were monitored until complete recovery, and the outcome was recorded. The data were analyzed using SPSS version 25 (IBM SPSS Corp.; Armonk, NY, USA). RESULTS: Hepatitis A was the most common etiology (76.6%) of AVH. Other etiologies include hepatitis E (1.6%), hepatitis C (0.6%), non-A-E hepatitis (6.3%), dengue hepatitis (1.9%), hepatitis A virus (HAV) + hepatitis E virus (4.4%), HAV + dengue (0.6%), and HAV + Salmonella (8.2%). A total of 41.1% of patients developed atypical features with complications. The overall mortality rate was 6.3% (10 children). Splenomegaly, ascites, bleeding manifestations, hemolysis, pleural effusion, features of encephalopathy and acute liver failure, raised serum bilirubin, prolonged PT (prothrombin time) and INR (international normalization ratio), and low albumin showed a significant difference between survivor and non-survivor groups. CONCLUSION: Hepatitis A virus is the leading cause of AVH, and the overall prognosis is good. The mortality rate was notably higher among boys. Splenomegaly, ascites, bleeding manifestations, hemolysis, pleural effusion, features of encephalopathy and acute liver failure, raised serum bilirubin, prolonged PT and INR, and low albumin would serve as possible predictors of mortality in pediatric AVH.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。